Polpharma Prospers Again On Dutch Natalizumab

 
• By Aidan Fry
  
Poland_Netherland_Gears
Poland's Polpharma has prevailed against Biogen in a Dutch dispute over a natalizumab patent • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin